Researchers have retracted and replaced a June 2016 paper in JAMA Internal Medicine after discovering errors in their data.
The paper explored whether Accountable Care Organizations (ACOs) — groups of health care providers who earn more when they deliver high-quality care without boosting costs — improve care and lower health care costs for Medicare patients. The paper’s corresponding author, Carrie H. Colla, and her colleagues examined Medicare data over five years and found the ACOs provided “ modest savings on average” and less hospital care.
But the data from the Centers for Medicare & Medicaid Services (CMS) contained errors. According to Colla, after the paper was published, CMS “let us know in the fall  that there were errors in the files, but weren’t able to give us final replacement files until winter.” Continue reading Errors in govt database prompt authors to retract and replace paper in JAMA journal
Last week, JAMA issued some unusual notices, letting readers know they should use caution when reading an editorial and letters associated with now-retracted articles by a bone researcher in Japan.
The notices — for papers by Yoshihiro Sato, now up to 14 retractions — remind readers not to heed the results of the now-retracted papers, and alert them to read any associated materials (specifically, an editorial in JAMA and letters in JAMA Internal Medicine) with caution.
The text of the notices describes them as “formal correction notices;” we asked Annette Flanagin, executive managing editor at The JAMA Network, why they chose that approach, instead of an expression of concern or retraction:
Continue reading JAMA tells readers: “Caution advised.” Here’s why.
Researchers have retracted and replaced a 2014 paper in JAMA Internal Medicine after realizing a number of errors had affected the findings.
The authors note the mistakes do not have a significant impact on the overall proportion of heart patients who participated in cardiac rehab. However, a number of findings were affected, such as the difference in participation in cardiac rehab defined by race, and how the overall participation has changed throughout the years.
Therefore, JAMA Internal Medicine has published a lengthy notice of retraction and replacement, which explains the errors made in the original paper, and updated the first paper with a new version of the study.
The retraction and replacement notice, issued this week, starts: Continue reading Authors retract (and replace) cardiac rehab study in JAMA journal
JAMA and another journal in its network have retracted three 2005 papers about preventing hip fractures, after an admission of scientific misconduct.
All papers are being retracted over concerns about data integrity, and “inappropriate assignment of authorship.” Four of the authors — all based in Japan — have co-authored all of the three newly retracted papers, and also share authorship of a previous retraction from 2015.
The JAMA paper was tagged with an Expression of Concern last year, regarding the “conduct, integrity, and scientific validity” of the paper.
Here’s the retraction notice for the JAMA paper, “Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke:” Continue reading JAMA journals pull 3 papers by same authors for misconduct
For decades, the U.S. FDA has uncovered misconduct in clinical trials but hidden it from the public, according to a new paper in JAMA Internal Medicine.
The study, by New York University journalism professor Charles Seife, looked at 78 publications resulting from trials where the FDA found serious misconduct, including “failure to protect the safety of patients” and data fakery. Only three of those publications mentioned the problems uncovered by the FDA. No retractions or errata were ever issued for any of them.
For example, in one of the three cases: Continue reading “FDA has repeatedly hidden evidence of scientific fraud,” says author of new study